Silverback Therapeutics (SBTX) PT Lowered to $32 at Stifel
Tweet Send to a Friend
Stifel analyst Stephen Willey lowered the price target on Silverback Therapeutics (NASDAQ: SBTX) to $32.00 (from $54.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
